Pēdējā atjaunošana :
19/11/2024
Infostab
Saraksti
Kopsavilkums
Meklēt saderības
Y-savienojuma saderības tabula
Literatūras saraksts
pētniecības grupas
valistab
plakāts
Savienojumi
sponsori
Autori
Lietošanas instrukcija
Newsletter
Ertapenem
Ķīmiskā uzbūve
Oriģinālais nosaukums
Tirdzniecības nosaukumi ir apzīmējoši un palīgvielas var atšķirties dažādām valstīm un laboratorijām
Ertacrit
Indija
Ertagram
Peru
Ertamac
Indija
Invanz
Amerikas Savienotās Valstis, Apvienotie Arābu Emirāti, Argentīna, Austrālija, Austrija, Brazīlija, Čīle, Dānija, Ēģipte, Ekvadora, Francija, Grieķija, Holande, Īrija, Islande, Itālija, Japāna, Jaunzēlande, Kanāda, Kolumbija, Lielbritānija, Luksemburga, Malaizija, Maroka, Meksika, Norvēģija, Peru, Polija, Portugāle, Rumānija, Somija, Spānija, Šveice, Turcija, Ungārija, Vācija, Venecuēla, Zviedrija
Lyortam
Čīle, Peru
Literatūras saraksts : Ertapenem
tips
publicēšana
1906
Žurnāls
McQuade MS, Van Nostrand V, Shariter J, Kanike JD, Forsyth RJ.
Stability and compatibility of reconstituted ertapenem with commonly used iv infusion and coinfusion solutions.
Am J Health-Syst Pharm 2004 ; 61: 38-45.
1912
Laboratorija
Ertapenem (Invanz®) - Summary of Product Characteristics
Merck Sharp Dohme 2016
1982
Žurnāls
Trissel LA, Ogundele AB.
Compatibility of anidulafungin with other drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2005 ; 62: 834-837.
2178
Žurnāls
Zajac M, Cielecka-Piontek J, Jelinska A.
Stability of ertapenem in aqueous solutions.
J Pharm Biomed Anal 2007 ; 43: 445-449.
2247
Žurnāls
Chan P, Heatherly K, Kupiec T.C, Trissel L.A.
Compatibility of caspofungin acetate injection with other drugs during simulated Y-site coadministration.
Int J Pharm Compound 2008 ; 12, 3: 276-278.
3208
Žurnāls
Phipps Stephen D, Peacock Gina F, Smith Douglas L .
Stability of Ertapenem in an Elastomeric Infusion Device.
Int J Pharm Compound 2011 ; 15, 3: 252-254.
3254
Žurnāls
Housman S.T, Tessier P.R, Nicolau D.P, Kuti J.L.
Physical compatibility of telavancin hydrochloride with select i.v. drugs during simulated Y-site administration
Am J Health-Syst Pharm 2011 ; 68: 2265-2270.
3549
Laboratorija
Amikacine B Braun - Résumé des caractéristiques du produit.
B Braun 2012
3674
Laboratorija
Erythromycin lactobionate - Summary of Product Characteristics
PanPharma 2016
3717
Žurnāls
Jain J.G, Sutherland C, Nicolau D.P, Kuti J.L.
Stability of ertapenem 100 mg/mL in polypropylene syringes stored at 25, 4, and -20 °C.
Am J Health-Syst Pharm 2014 ; 71:1480-1484
3824
Žurnāls
Boudi S, Roy H, Forest JM, Leclair G.
Compatibilité physique de l'association amoxicilline-acide clavulanique en injection avec plusieurs autres médicaments lors d'une administration en Y.
Pharmactuel 2023 2023;56,3:91-98
3827
plakāts
Ghazi I.M, Hamada Y, Nicolau D.P.
Compatibility of tedizolid phosphate with selected intravenous drugs via simulated Y-site conditions.
ASHP Midyear 2015
3828
plakāts
Thabit A.K, Hamada Y, Nicolau D.P.
Ceftozolane/tazobactam physical compatibility during simulated Y-site administration.
ASHP Midyear 2015
3829
plakāts
So W, Kim L, Thabit A.K, Nicolau D.P, Kuti J.L.
Compatibility of isavunazonium sulfate during simulated Y-site administration.
ASHP Midyear 2015
3891
Žurnāls
Walker S.E, Law S, Perks W, Iazzetta J.
Stability of Ertapenem 100 mg/mL in Manufacturer’s Glass Vials or Syringes at 4°C and 23°C
Can J Hosp Pharm 2015 ; 68, 2: 121-126.
3997
Žurnāls
Katip W.
Visual compatibility of colistin injection with other antibiotics during simulated Y-site administration.
Am J Health-Syst Pharm 2017 ; 74:14 : 1099-1102
4055
Žurnāls
Monogue M, Almarzoky Abuhussain S, Kuti J, Nicolau D.
Physical compatibility of fosfomycin for injection with select i.v. drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2018 , 75, 1:36-44
4145
Žurnāls
Asempa T.E, Avery L.M, Kidd J.M, Kuti J.L, Nicolau D.P.
Physical compatibility of plazomicin with select i.v. drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2018 ;75,14:1048-1056
4319
Žurnāls
Lessard J-J, Caron E, Schérer H, Forest J-M, Leclair G.
Compatibility of Y-site Injection of Meropenem Trihydrate With 101 Other Injectable Drugs.
Hosp Pharm 2020 ; 55, 5: 332-337.
4528
Žurnāls
Lu J, Liu Q, Kupiec T, Vail H, Lunch L, Fam D, Vu N.
Physical Compatibility of Cefiderocol with Selected Intravenous Drugs During Simulated Y-site Administration.
Int J Pharm Compound 2021 ;25,1:52-61
4742
Žurnāls
Macoviciuc M, Nguyen C, Forest J-M, Leclair G.
Compatibilité physique de l’acétaminophène injectable avec 102 autres médicaments lors d’une administration en Y.
Pharmactuel 2022 ; 55, 4: 247-255.
4801
Žurnāls
Ruiz V, Yuwei Shen Y, Abouelhassan Y, Fouad A, Nicolau D, Kuti J.
Physical compatibility of sulbactam/durlobactam with select intravenous drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2024 ;51,1:
Mentions Légales